| Financial Year |
March 31 2023 |
| Monetary Funds |
1,442,235,874.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
193,101,088.15 |
| Accounts Receivable |
802,718,225.43 |
| Advances to Suppliers |
85,576,779.44 |
| Other Receivables |
35,047,508.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,312,244,578.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,161,071.71 |
| Total Current Assets |
4,018,633,103.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
173,199,157.19 |
| Investment Properties |
65,423,137.98 |
| Fixed Assetes |
1,424,539,709.93 |
| Under-construction Projects |
146,940,602.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,314,433.42 |
| R&D expenses |
-- |
| Goodwill |
76,616,519.04 |
| Long-Term Deferred and Prepaid Expenses |
24,099,058.44 |
| Deferred Income Tax Assets |
74,430,035.95 |
| Other Non-Current Assets |
53,288,615.28 |
| Sub-Total of Non-Current Assets |
2,422,870,781.07 |
| Total Assets |
6,441,503,884.41 |
| Short-Term Loans |
195,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
635,895,729.62 |
| Accounts Payable |
1,455,787,746.77 |
| Accounts Received In Advance |
619,339.00 |
| Employee Compensation Payable |
41,070,540.81 |
| Taxes Payable |
51,028,394.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,718,235.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,375,494.45 |
| Other Current Liabilities |
9,003,393.00 |
| Sub-Total of Current Liabilities |
2,480,821,021.15 |
| Long-term Loans |
169,210,632.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
61,001,757.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
327,253,834.93 |
| Total Liabilities |
2,808,074,856.08 |
| Paid-In Capital(Or Share Stock) |
439,040,000.00 |
| Capital Surplus |
1,269,358,995.49 |
| Surplus Reserve |
178,320,811.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,394,808,023.52 |
| Minority Stockholder's Interest |
351,901,197.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,281,527,830.92 |
| Owner's Equity（Stockholder's Equity） |
3,633,429,028.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,441,503,884.41 |
